| 摘要 |
Provided are a novel myogenesis accelerator, amyotrophy suppressor, medicinal composition, and TAZ activator. The myogenesis accelerator, amyotrophy suppressor, medicinal composition, and TAZ activator according to the present invention contain as an active ingredient a compound represented by general formula (1). [In general formula (1), R1 represents a hydrogen atom or an alkyl group. R2 represents an aryl group, a heterocyclic group, an alkyl group, or the like. R3 represents -NR5R6 or -N=C-R7, R5 and R6 each independently represent a hydrogen atom, an alkyl group, or the like, or represent -C(=O)R8 or -COOR9, R7 represents -NR10R11, an aryl group, or a heterocyclic group, R8 represents a hydrogen atom, an alkyl group, or the like, R9 represents a hydrogen atom, an alkyl group, or the like, and R10 and R11 each independently represent a hydrogen atom or an alkyl group. R4 represents a cyano group or -C(=O)R12, and R12 represents an aryl group, a heterocyclic group, an alkyl group, or the like.] |
